Ticker: KVUE
Kenvue
Healthcare
Consumer Staples
Household & Personal Products
Price
17.79
Reco
Sell
Potential
45
Risk
65
Updated
2026-09-11
Track in portfolio
Price chart
AI recommendation
Analyst forecast
Calendar event
Positive signal
Negative signal
Neutral / update
Hold / informational
B My buy
S My sell
Description
Company and Business Model
Kenvue (KVUE.US) operates in the consumer staples sector, focusing on personal care and hygiene products. Its core offerings include over-the-counter medications, skincare, and household cleaning products. Major business segments encompass health and wellness, beauty, and home care, with primary revenue sources derived from product sales in retail and e-commerce channels.
Investment Profile
The investment profile of Kenvue is more aligned with dividend investors due to its notable dividend yield of 6.0%. The stock exhibits moderate growth potential, making it suitable for those seeking a balance between income and capital appreciation. Its relatively stable performance and low volatility suggest a lower risk profile, appealing to investors with a medium to long-term horizon.
Category: Healthcare
Sector: Consumer Staples
Industry: Household & Personal Products
Investment style: Growth
Horizon: Medium-term
Company type: Blue Chip
Company type: Large Cap
Fundamental metrics (experimental) Updated: 2026-09-07
- EPS (TTM) — earnings per share for the last 12 months, $
- 0.87
- Revenue QoQ — quarter-over-quarter revenue growth
- 1.2%
- EPS surprise
- -2.7%
- 20d volatility
- 1.1%
- Dividend yield
- 4.4%
- last ex-date
- 2026-08-12
AI recommendation changes
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-09-10 | Hold | Sell | Weak momentum and high risk overshadow dividend yield. |
| 2026-08-31 | Buy | Hold | Stable dividend, but mixed performance signals and risks. |
| 2026-08-20 | Sell | Buy | Stable dividend, but mixed momentum and fundamentals. |
| 2026-08-18 | Buy | Sell | Weak momentum and fundamentals raise uncertainty. |
| 2026-06-10 | Hold | Buy | Strong fundamentals and solid dividend yield support growth. |
| 2026-05-30 | Buy | Hold | Stable dividend, but weak momentum and high risk. |
| 2026-05-22 | Hold | Buy | Stable dividend, moderate growth, mixed momentum signals. |
| 2026-05-16 | Buy | Hold | Stable dividend, but weak momentum and high risk. |
| 2026-05-08 | — | Buy | Stable dividend yield, but mixed momentum signals. |
| 2026-05-05 | Buy | Hold | Компания показывает стабильные показатели, но недавнее снижение цен и низкий рост выручки вызывают осторожность. Дивидендная доходность привлекательна, что может поддерживать интерес инвесторов. |
| 2026-04-13 | Hold | Buy | Компания Kenvue демонстрирует стабильный рост за последние 120 дней и имеет привлекательную дивидендную доходность. Учитывая положительные финансовые показатели и умеренный риск, инвестиции в акции могут быть оправданы. |
| 2026-04-05 | Buy | Hold | Компания показывает стабильный дивидендный доход и умеренный рост выручки, однако недавние колебания цен и снижение на коротких интервалах вызывают опасения. Рекомендуется удерживать акции до более ясных сигналов о восст |
| 2026-03-25 | Hold | Buy | Компания показывает стабильный рост в долгосрочной перспективе, однако недавние колебания цен и снижение на коротких временных интервалах могут указывать на временные трудности. |
| 2026-03-12 | Buy | Hold | Компания демонстрирует стабильный дивидендный доход и положительный сюрприз по прибыли, однако недавние колебания цен и низкий рост выручки вызывают опасения. |
| 2026-02-24 | Hold | Buy | Компания демонстрирует стабильный рост выручки и дивидендную доходность, однако недавнее снижение цен на акции за 120 дней вызывает осторожность. |
Analyst forecasts
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-21 | Barclays | Target Raised | 18 → 19 | 19.02 |
| 2026-07-16 | UBS | Target Raised | 18 → 20 | 18.91 |
| 2026-04-14 | Barclays | Target Lowered | 19 → 18 | 17.385 |
| 2026-02-18 | UBS | Target Raised | 17 → 19 | 18.41 |
| 2026-02-18 | Canaccord Genuity | Target Raised | 17 → 18 | 18.41 |
| 2026-01-30 | Jefferies | Rating Downgraded | — → 18 | 17.2 |
| 2025-10-29 | Canaccord Genuity | Rating Downgraded | — → 15 | 14.51 |
| 2025-10-28 | Evercore ISI | Update | — → 18 | 14.495 |
| 2025-10-27 | Jefferies | Target Lowered | — → 23 | 15 |
| 2025-10-24 | Deutsche Bank | Target Lowered | 20 → 18 | 15.065 |
| 2025-10-08 | UBS | Target Lowered | 23 → 17 | 16.205 |
| 2025-10-01 | Barclays | Target Lowered | 20 → 17 | 16.23 |
News Page 1 of 1
Nothing yet